Search Within

Sergio Andres Giralt

  1. "Sean Devlin"
Formats
  1. Meeting Abstract (244)
  2. Journal Article (124)
  3. Research Letter (10)
  4. Correspondence (2)
Groups
  1. Biostatistics Service (380)
  2. Bone Marrow Transplant (380)
  3. Center for Hematologic Malignancies (380)
  4. Department of Medicine (380)
  5. Epidemiology and Biostatistics (380)
  6. Hematologic Malignancies, Division of (380)

More Groups

People
  1. Sean Devlin (380)
  2. Miguel-Angel Perales (242)
  3. Gunjan Shah (149)
  4. Molly Maloy (144)
  5. Parastoo Dahi (131)
  6. Ann Jakubowski (128)

More People

Years
  1. 2025 (7)
  2. 2024 (13)
  3. 2023 (28)
  4. 2022 (29)
  5. 2021 (23)
  6. 2020 (39)

More Years

Publications
  1. Blood (119)
  2. Biology of Blood and Marrow Transplantation (115)
  3. Bone Marrow Transplantation (39)
  4. Transplantation and Cellular Therapy (19)
  5. Blood Advances (16)
  6. Leukemia and Lymphoma (14)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Hematology (135)
  3. Nature Publishing Group (46)
  4. Taylor & Francis Group (14)
  5. American Society of Clinical Oncology (8)
  6. Ferrata Storti Foundation (5)

More Publishers

Results (380)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients
    Research Letter

    Jeng, M. Y.; Wong, P.; Flynn, J. R.; Ritter, E.; Ho, C.; Ruiz, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; Shaffer, B. C.; Ponce, D. R.; more...
    Journal of Geriatric Oncology (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation
    Journal Article

    Fein, J. A.; McAuliffe, A.; Fischer, K.; Brady, O.; Devlin, S. M.; Willumsen, S.; Ozcan, G.; Montanaro, P.; Pristyazhnyuk, Y.; DiGiuseppe, J.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save